Uniqure NV (NASDAQ:QURE)
| 17.83 Delayed Data As of 4:00pm ET |  -0.20 / -1.11%Today’s Change | 16.83 Today|||52-Week Range 40.49 | -14.03% Year-to-Date |
Latest QURE News | Press Releases
| 3 High Return Non-Cyclical Stocks Jan 20 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 18.03 |
| Today’s open | 17.56 |
| Day’s range | 17.20 - 18.26 |
| Volume | 21,264 |
| Average volume (3 months) | 650,353 |
| Market cap | $837.6M |
Data as of 4:00pm ET, 01/25/2022
Growth & Valuation
| Earnings growth (last year) | +9.45% |
| Earnings growth (this year) | +319.54% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +415.23% |
| P/E ratio | 2.6 |
| Price/Sales | 42.83 |
| Price/Book | 3.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SGMOSangamo Therapeutics... | +0.04 | +0.67% |
| HRTXHeron Therapeutics I... | +0.36 | +4.16% |
| ---- | ||
| ANABAnaptysBio Inc | +0.05 | +0.15% |
Data as of 4:00pm ET, 01/25/2022
Financials
| Next reporting date | March 16, 2022 |
| EPS forecast (this quarter) | -$0.82 |
| Annual revenue (last year) | $37.5M |
| Annual profit (last year) | -$125.0M |
| Net profit margin | -333.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Amsterdam, Noord-holland |
Forecasts
